High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis
Publication date
2022-11
Authors
Te Linde, Elsemieke
Boots, Laura J E
Daenen, Laura G M
de Witte, Moniek
Bruns, Anke
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by
Abstract
Keywords
Hematology, Journal Article
Citation
Te Linde, E, Boots, L J E, Daenen, L G M, de Witte, M A & Bruns, A H W 2022, 'High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms : Need for Prophylaxis', HemaSphere, vol. 6, no. 11, e793. https://doi.org/10.1097/HS9.0000000000000793